BMY logo

Bristol-Myers Squibb (BMY) Depreciation and amortization

annual D&A:

$9.60B-$160.00M(-1.64%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BMY annual depreciation & amortization is $9.60 billion, with the most recent change of -$160.00 million (-1.64%) on December 31, 2024.
  • During the last 3 years, BMY annual D&A has fallen by -$1.09 billion (-10.16%).
  • BMY annual D&A is now -10.16% below its all-time high of $10.69 billion, reached on December 31, 2021.

Performance

BMY Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

quarterly D&A:

$1.01B-$868.00M(-46.17%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BMY quarterly depreciation & amortization is $1.01 billion, with the most recent change of -$868.00 million (-46.17%) on March 31, 2025.
  • Over the past year, BMY quarterly D&A has dropped by -$1.52 billion (-60.03%).
  • BMY quarterly D&A is now -62.89% below its all-time high of $2.73 billion, reached on September 30, 2021.

Performance

BMY quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

TTM D&A:

$8.08B-$1.52B(-15.83%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BMY TTM depreciation & amortization is $8.08 billion, with the most recent change of -$1.52 billion (-15.83%) on March 31, 2025.
  • Over the past year, BMY TTM D&A has dropped by -$1.78 billion (-18.08%).
  • BMY TTM D&A is now -25.16% below its all-time high of $10.80 billion, reached on September 30, 2021.

Performance

BMY TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

BMY Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1.6%-60.0%-18.1%
3 y3 years-10.2%-60.8%-23.8%
5 y5 years+449.8%-59.1%+99.4%

BMY Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.2%at low-61.0%at low-23.8%at low
5 y5-year-10.2%+449.8%-62.9%at low-25.2%+99.4%
alltimeall time-10.2%+4798.0%-62.9%+1924.0%-25.2%>+9999.0%

BMY Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.01B(-46.2%)
$8.08B(-15.8%)
Dec 2024
$9.60B(-1.6%)
$1.88B(-27.5%)
$9.60B(-5.7%)
Sep 2024
-
$2.59B(-0.2%)
$10.18B(+1.6%)
Jun 2024
-
$2.60B(+2.5%)
$10.03B(+1.7%)
Mar 2024
-
$2.53B(+2.8%)
$9.86B(+1.1%)
Dec 2023
$9.76B(-5.0%)
$2.46B(+1.2%)
$9.76B(-0.6%)
Sep 2023
-
$2.44B(+0.1%)
$9.82B(-1.5%)
Jun 2023
-
$2.43B(+0.1%)
$9.97B(-1.5%)
Mar 2023
-
$2.43B(-3.6%)
$10.12B(-1.5%)
Dec 2022
$10.28B(-3.8%)
$2.52B(-2.6%)
$10.28B(-0.6%)
Sep 2022
-
$2.59B(+0.2%)
$10.33B(-1.3%)
Jun 2022
-
$2.58B(-0.0%)
$10.47B(-1.2%)
Mar 2022
-
$2.58B(+0.2%)
$10.60B(-0.8%)
Dec 2021
$10.69B(+2.9%)
$2.58B(-5.4%)
$10.69B(-1.0%)
Sep 2021
-
$2.73B(+0.6%)
$10.80B(+0.7%)
Jun 2021
-
$2.71B(+1.6%)
$10.72B(+1.5%)
Mar 2021
-
$2.67B(-0.8%)
$10.57B(+1.8%)
Dec 2020
$10.38B(+494.5%)
$2.69B(+1.3%)
$10.38B(+16.3%)
Sep 2020
-
$2.65B(+3.8%)
$8.93B(+38.6%)
Jun 2020
-
$2.56B(+3.3%)
$6.44B(+58.9%)
Mar 2020
-
$2.48B(+100.4%)
$4.05B(+132.1%)
Dec 2019
$1.75B(+174.1%)
$1.24B(+622.8%)
$1.75B(+156.0%)
Sep 2019
-
$171.00M(+1.2%)
$682.00M(+0.9%)
Jun 2019
-
$169.00M(-0.6%)
$676.00M(+1.8%)
Mar 2019
-
$170.00M(-1.2%)
$664.00M(+4.2%)
Dec 2018
$637.00M(-19.3%)
$172.00M(+4.2%)
$637.00M(-3.8%)
Sep 2018
-
$165.00M(+5.1%)
$662.00M(-3.4%)
Jun 2018
-
$157.00M(+9.8%)
$685.00M(-7.3%)
Mar 2018
-
$143.00M(-27.4%)
$739.00M(-6.3%)
Dec 2017
$789.00M(+106.5%)
$197.00M(+4.8%)
$789.00M(+10.5%)
Sep 2017
-
$188.00M(-10.9%)
$714.00M(+13.2%)
Jun 2017
-
$211.00M(+9.3%)
$631.00M(+23.7%)
Mar 2017
-
$193.00M(+58.2%)
$510.00M(+33.5%)
Dec 2016
$382.00M(+1.6%)
$122.00M(+16.2%)
$382.00M(+13.7%)
Sep 2016
-
$105.00M(+16.7%)
$336.00M(0.0%)
Jun 2016
-
$90.00M(+38.5%)
$336.00M(-0.3%)
Mar 2016
-
$65.00M(-14.5%)
$337.00M(-10.4%)
Dec 2015
$376.00M(-19.5%)
$76.00M(-27.6%)
$376.00M(-6.7%)
Sep 2015
-
$105.00M(+15.4%)
$403.00M(-1.7%)
Jun 2015
-
$91.00M(-12.5%)
$410.00M(-5.5%)
Mar 2015
-
$104.00M(+1.0%)
$434.00M(-7.1%)
Dec 2014
$467.00M(-38.8%)
$103.00M(-8.0%)
$467.00M(-14.3%)
Sep 2014
-
$112.00M(-2.6%)
$545.00M(-11.1%)
Jun 2014
-
$115.00M(-16.1%)
$613.00M(-10.8%)
Mar 2014
-
$137.00M(-24.3%)
$687.00M(-10.0%)
Dec 2013
$763.00M(+12.0%)
$181.00M(+0.6%)
$763.00M(-2.3%)
Sep 2013
-
$180.00M(-4.8%)
$781.00M(-1.9%)
Jun 2013
-
$189.00M(-11.3%)
$796.00M(+5.4%)
Mar 2013
-
$213.00M(+7.0%)
$755.00M(+10.9%)
Dec 2012
$681.00M(+8.4%)
$199.00M(+2.1%)
$681.00M(+8.4%)
Sep 2012
-
$195.00M(+31.8%)
$628.00M(+21.0%)
Jun 2012
-
$148.00M(+6.5%)
$519.00M(-10.1%)
Mar 2012
-
$139.00M(-4.8%)
$577.00M(-8.1%)
Dec 2011
$628.00M(+3.5%)
$146.00M(+69.8%)
$628.00M(+15.7%)
Sep 2011
-
$86.00M(-58.3%)
$543.00M(-13.1%)
Jun 2011
-
$206.00M(+8.4%)
$625.00M(+2.5%)
Mar 2011
-
$190.00M(+211.5%)
$610.00M(+0.5%)
Dec 2010
$607.00M(-14.1%)
$61.00M(-63.7%)
$607.00M(-16.6%)
Sep 2010
-
$168.00M(-12.0%)
$728.00M(-1.8%)
Jun 2010
-
$191.00M(+2.1%)
$741.00M(+1.9%)
Mar 2010
-
$187.00M(+2.7%)
$727.00M(+2.8%)
Dec 2009
$707.00M(-13.4%)
$182.00M(+0.6%)
$707.00M(+0.3%)
Sep 2009
-
$181.00M(+2.3%)
$705.00M(-0.1%)
Jun 2009
-
$177.00M(+6.0%)
$706.00M(-3.6%)
Mar 2009
-
$167.00M(-7.2%)
$732.00M(-10.3%)
Dec 2008
$816.00M(-8.5%)
$180.00M(-1.1%)
$816.00M(-8.3%)
Sep 2008
-
$182.00M(-10.3%)
$890.00M(-3.4%)
Jun 2008
-
$203.00M(-19.1%)
$921.00M(-0.6%)
Mar 2008
-
$251.00M(-1.2%)
$927.00M(+3.9%)
Dec 2007
$892.00M
$254.00M(+19.2%)
$892.00M(+2.3%)
Sep 2007
-
$213.00M(+1.9%)
$872.00M(-1.9%)
DateAnnualQuarterlyTTM
Jun 2007
-
$209.00M(-3.2%)
$889.00M(-3.1%)
Mar 2007
-
$216.00M(-7.7%)
$917.00M(-1.1%)
Dec 2006
$927.00M(-0.2%)
$234.00M(+1.7%)
$927.00M(-0.5%)
Sep 2006
-
$230.00M(-3.0%)
$932.00M(+1.4%)
Jun 2006
-
$237.00M(+4.9%)
$919.00M(+0.8%)
Mar 2006
-
$226.00M(-5.4%)
$912.00M(-1.8%)
Dec 2005
$929.00M(+2.2%)
$239.00M(+10.1%)
$929.00M(-1.7%)
Sep 2005
-
$217.00M(-5.7%)
$945.00M(-2.2%)
Jun 2005
-
$230.00M(-5.3%)
$966.00M(+1.9%)
Mar 2005
-
$243.00M(-4.7%)
$948.00M(+4.3%)
Dec 2004
$909.00M(+15.2%)
$255.00M(+7.1%)
$909.00M(+2.2%)
Sep 2004
-
$238.00M(+12.3%)
$889.00M(+5.6%)
Jun 2004
-
$212.00M(+3.9%)
$842.00M(+3.3%)
Mar 2004
-
$204.00M(-13.2%)
$815.00M(+3.3%)
Dec 2003
$789.00M(+7.3%)
$235.00M(+23.0%)
$789.00M(+6.6%)
Sep 2003
-
$191.00M(+3.2%)
$740.00M(+0.4%)
Jun 2003
-
$185.00M(+3.9%)
$737.00M(+0.4%)
Mar 2003
-
$178.00M(-4.3%)
$734.00M(-0.1%)
Dec 2002
$735.00M(+1.0%)
$186.00M(-1.1%)
$735.00M(-5.4%)
Sep 2002
-
$188.00M(+3.3%)
$777.00M(+7.0%)
Jun 2002
-
$182.00M(+1.7%)
$726.00M(+0.6%)
Mar 2002
-
$179.00M(-21.5%)
$722.00M(-0.8%)
Dec 2001
$728.00M(-2.4%)
$228.00M(+66.4%)
$728.00M(+6.1%)
Sep 2001
-
$137.00M(-23.0%)
$686.00M(-6.8%)
Jun 2001
-
$178.00M(-3.8%)
$736.00M(-1.1%)
Mar 2001
-
$185.00M(-0.5%)
$744.00M(-0.3%)
Dec 2000
$746.00M(+10.0%)
$186.00M(-0.5%)
$746.00M(-0.4%)
Sep 2000
-
$187.00M(+0.5%)
$749.00M(+4.0%)
Jun 2000
-
$186.00M(-0.5%)
$720.00M(+3.2%)
Mar 2000
-
$187.00M(-1.1%)
$698.00M(+2.9%)
Dec 1999
$678.00M(+8.5%)
$189.00M(+19.6%)
$678.00M(+3.2%)
Sep 1999
-
$158.00M(-3.7%)
$657.00M(+0.3%)
Jun 1999
-
$164.00M(-1.8%)
$655.00M(+2.8%)
Mar 1999
-
$167.00M(-0.6%)
$637.00M(+1.9%)
Dec 1998
$625.00M(+5.8%)
$168.00M(+7.7%)
$625.00M(-2.2%)
Sep 1998
-
$156.00M(+6.8%)
$639.00M(+2.6%)
Jun 1998
-
$146.00M(-5.8%)
$623.00M(+1.8%)
Mar 1998
-
$155.00M(-14.8%)
$612.00M(+3.6%)
Dec 1997
$591.00M(+13.9%)
$182.00M(+30.0%)
$591.00M(+7.8%)
Sep 1997
-
$140.00M(+3.7%)
$548.00M(+2.6%)
Jun 1997
-
$135.00M(+0.7%)
$534.00M(+2.3%)
Mar 1997
-
$134.00M(-3.6%)
$522.00M(+0.6%)
Dec 1996
$519.00M(+15.8%)
$139.00M(+10.3%)
$519.00M(-8.8%)
Sep 1996
-
$126.00M(+2.4%)
$569.00M(+7.4%)
Jun 1996
-
$123.00M(-6.1%)
$530.00M(+7.5%)
Mar 1996
-
$131.00M(-30.7%)
$493.00M(+10.0%)
Dec 1995
$448.00M(+36.6%)
$189.00M(+117.2%)
$448.00M(+29.9%)
Sep 1995
-
$87.00M(+1.2%)
$345.00M(+1.5%)
Jun 1995
-
$86.00M(0.0%)
$340.00M(+1.8%)
Mar 1995
-
$86.00M(0.0%)
$334.00M(+1.8%)
Dec 1994
$328.00M(+6.5%)
$86.00M(+4.9%)
$328.00M(+2.5%)
Sep 1994
-
$82.00M(+2.5%)
$320.00M(+1.9%)
Jun 1994
-
$80.00M(0.0%)
$314.00M(+0.6%)
Mar 1994
-
$80.00M(+2.6%)
$312.00M(+1.3%)
Dec 1993
$308.00M(+4.4%)
$78.00M(+2.6%)
$308.00M(-0.6%)
Sep 1993
-
$76.00M(-2.6%)
$310.00M(+0.3%)
Jun 1993
-
$78.00M(+2.6%)
$309.00M(+2.3%)
Mar 1993
-
$76.00M(-5.0%)
$302.00M(+2.4%)
Dec 1992
$295.00M(+19.9%)
$80.00M(+6.7%)
$295.00M(+8.9%)
Sep 1992
-
$75.00M(+5.6%)
$271.00M(+3.8%)
Jun 1992
-
$71.00M(+2.9%)
$261.00M(+8.8%)
Mar 1992
-
$69.00M(+23.2%)
$240.00M(-2.4%)
Dec 1991
$246.00M(+0.8%)
$56.00M(-13.8%)
$246.00M(-2.4%)
Sep 1991
-
$65.00M(+30.0%)
$252.00M(+2.0%)
Jun 1991
-
$50.00M(-33.3%)
$247.00M(-3.9%)
Mar 1991
-
$75.00M(+21.0%)
$257.00M(+5.3%)
Dec 1990
$244.00M(+24.5%)
$62.00M(+3.3%)
$244.00M(+34.1%)
Sep 1990
-
$60.00M(0.0%)
$182.00M(+49.2%)
Jun 1990
-
$60.00M(-3.2%)
$122.00M(+96.8%)
Mar 1990
-
$62.00M
$62.00M
Dec 1989
$196.00M
-
-

FAQ

  • What is Bristol-Myers Squibb annual depreciation & amortization?
  • What is the all time high annual D&A for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual D&A year-on-year change?
  • What is Bristol-Myers Squibb quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly D&A year-on-year change?
  • What is Bristol-Myers Squibb TTM depreciation & amortization?
  • What is the all time high TTM D&A for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb TTM D&A year-on-year change?

What is Bristol-Myers Squibb annual depreciation & amortization?

The current annual D&A of BMY is $9.60B

What is the all time high annual D&A for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual depreciation & amortization is $10.69B

What is Bristol-Myers Squibb annual D&A year-on-year change?

Over the past year, BMY annual depreciation & amortization has changed by -$160.00M (-1.64%)

What is Bristol-Myers Squibb quarterly depreciation & amortization?

The current quarterly D&A of BMY is $1.01B

What is the all time high quarterly D&A for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly depreciation & amortization is $2.73B

What is Bristol-Myers Squibb quarterly D&A year-on-year change?

Over the past year, BMY quarterly depreciation & amortization has changed by -$1.52B (-60.03%)

What is Bristol-Myers Squibb TTM depreciation & amortization?

The current TTM D&A of BMY is $8.08B

What is the all time high TTM D&A for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high TTM depreciation & amortization is $10.80B

What is Bristol-Myers Squibb TTM D&A year-on-year change?

Over the past year, BMY TTM depreciation & amortization has changed by -$1.78B (-18.08%)
On this page